Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 463
Immune Disorders Drugs 194
Cardiovascular Drugs 153
Biopharmaceuticals 132
Infectious Diseases Drugs 121
Drug Discovery 104
Central Nervous System Drugs 104
Endocrine and Metabolic Disorders Drugs 102
Musculoskeletal Disorders Drugs 93
Pharmaceuticals 90
Clinical Trials 90
Leukemia Drugs 82
Hematological Drugs 81
Liver and Kidney Disorders Drugs 74
Lymphoma Drugs 64
Dermatological Drugs 60
Diabetes Drugs 53
Skin Cancer Drugs 50
Brain Cancer Drugs 47
Mental Disorders Drugs 41
Lung Cancer Drugs 40
Respiratory Drugs 38
Immunosuppressive Drugs 36
Gastrointestinal Drugs 34
Drug Delivery 32
Pharmaceutical Intermediates 30
Liver Cancer Drugs 30
Infusions and Injectables 30
Pharmaceutical Manufacturing 27
Analgesics 26
Bladder Cancer Drugs 25
Drugs by Therapeutic Area 23
Kidney Cancer Drugs 22
Antibiotics 22
HIV/AIDS Drugs 22
Breast Cancer Drugs 18
Ovarian Cancer Drugs 17
Colon Cancer Drugs 17
Cervical Cancer Drugs 17
Pancreatic Cancer Drugs 17
Psoriasis Drugs 17
Prostate Cancer Drugs 16
Urological Disorders Drugs 16
Schizophrenia Drugs 15
Thyroid Cancer Drugs 14
Sexual and Reproductive Health Drugs 14
Cancer Vaccines 13
Over the Counter (OTC) Drugs 12
Biosimilars and Biosuperiors 10
Optical Disorders Drugs 8
Generic Drugs 8
Alzheimer's Disease Drugs 8
Transdermal and Transmucosal Drug Delivery 7
Vaccines 7
Uterine Cancer Drugs 7
Cough and Cold Drugs 6
Anti-Obesity Drugs 6
Anxiety Drugs 6
Company Reports 5
Pharmacoeconomics 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



282 reviews

2,373 Results (Page 87 of 119)
- Relevance
  Sort by

PD-1/PD-L1 Checkpoint Inhibitors Market - Global Forecast 2026-2032

 Report
January 2026
194 Pages
Global

From

€3218EUR$3,545USD£2,772GBP

€3576EUR$3,939USD£3,080GBP

T-Cell Therapy Market by Indication, Therapy Type, Manufacturing Model, Cell Source, End User - Global Forecast 2026-2032

 Report
June 2026
191 Pages
Global

From

€3218EUR$3,545USD£2,772GBP

€3576EUR$3,939USD£3,080GBP

Bone Metastasis Market - Global Forecast 2026-2032

 Report
January 2026
192 Pages
Global

From

€3218EUR$3,545USD£2,772GBP

€3576EUR$3,939USD£3,080GBP

CD Antigen Cancer Therapy Market - Global Forecast 2026-2032

 Report
January 2026
195 Pages
Global

From

€3218EUR$3,545USD£2,772GBP

€3576EUR$3,939USD£3,080GBP

Esophageal Cancer Market - Global Forecast 2026-2032

 Report
January 2026
195 Pages
Global

From

€3218EUR$3,545USD£2,772GBP

€3576EUR$3,939USD£3,080GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

CAR-T Cell Service Market - Global Forecast 2026-2032

 Report
January 2026
183 Pages
Global

From

€3218EUR$3,545USD£2,772GBP

€3576EUR$3,939USD£3,080GBP

KRAS Inhibitor Market - Global Forecast 2026-2032

 Report
January 2026
182 Pages
Global

From

€3218EUR$3,545USD£2,772GBP

€3576EUR$3,939USD£3,080GBP

Vinca Alkaloid Compounds Market by Product Type, Dosage Form, Therapeutic Area, Brand Status, Treatment Regimen, Line of Therapy, End User - Global Forecast 2026-2032

 Report
June 2026
191 Pages
Global

From

€3218EUR$3,545USD£2,772GBP

€3576EUR$3,939USD£3,080GBP

Orphan Drugs Market by Therapeutic Area, Product Type, Administration Route, Patient Type, Payer Type, Distribution Channel, End User - Global Forecast 2026-2032

 Report
June 2026
199 Pages
Global

From

€3218EUR$3,545USD£2,772GBP

€3576EUR$3,939USD£3,080GBP

Leukemia Therapeutics Market Size, Share & Industry Trends Analysis Report By Drug Class (Targeted Therapy & Immunotherapy and Chemotherapy), By Distribution Channel, By Type, By Regional Outlook and Forecast, 2023 - 2029

 Report
May 2023
236 Pages
Global

From

€3268EUR$3,600USD£2,815GBP

Anti-Tumor Drugs Market by Drug Class, Molecule Type, Route of Administration, Therapy Line, Patient Age Group, Indication, Distribution Channel, End User - Global Forecast 2026-2032

 Report
June 2026
187 Pages
Global

From

€3218EUR$3,545USD£2,772GBP

€3576EUR$3,939USD£3,080GBP

MPYS Protein Stimulants - Pipeline Insight, 2025

 Drug Pipelines
April 2025
80 Pages
Global

From

€1815EUR$2,000USD£1,564GBP

Cancer Immunotherapy Drugs Market - Global Forecast 2026-2032

 Report
January 2026
191 Pages
Global

From

€3218EUR$3,545USD£2,772GBP

€3576EUR$3,939USD£3,080GBP

Cancer Cachexia Market - Global Forecast 2026-2032

 Report
January 2026
189 Pages
Global

From

€3218EUR$3,545USD£2,772GBP

€3576EUR$3,939USD£3,080GBP

Cellular Immunotherapy Market - Global Forecast 2026-2032

 Report
January 2026
192 Pages
Global

From

€3218EUR$3,545USD£2,772GBP

€3576EUR$3,939USD£3,080GBP

Stomach Cancer Treatment Market - Global Forecast 2026-2032

 Report
January 2026
197 Pages
Global

From

€3218EUR$3,545USD£2,772GBP

€3576EUR$3,939USD£3,080GBP

Cancer Therapeutics & Supportive Care Drugs Market by Drug Type, Route of Administration, Mechanism of Action, Indication, Distribution Channel, End User - Global Forecast 2026-2032

 Report
June 2026
191 Pages
Global

From

€3218EUR$3,545USD£2,772GBP

€3576EUR$3,939USD£3,080GBP

Cancer Biological Therapy Market by Therapy Type, Administration Route, Application, End User, Distribution Channel - Global Forecast 2026-2032

 Report
June 2026
184 Pages
Global

From

€3218EUR$3,545USD£2,772GBP

€3576EUR$3,939USD£3,080GBP

Cancer Gene Therapy Market - Global Forecast 2026-2032

 Report
January 2026
194 Pages
Global

From

€3218EUR$3,545USD£2,772GBP

€3576EUR$3,939USD£3,080GBP

Bone Cancer Treatment Market - Global Forecast 2026-2032

 Report
January 2026
186 Pages
Global

From

€3218EUR$3,545USD£2,772GBP

€3576EUR$3,939USD£3,080GBP

2,373 Results (Page 87 of 119)
- 1
- 85
- 86
- 87
- 88
- 89

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.